Fulgent Genetics, Inc.
FLGT
$21.77
$0.3751.75%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -64.41% | -95.82% | 59.80% | -68.17% | 35.30% |
| Total Depreciation and Amortization | 2.28% | -4.41% | 4.59% | -3.79% | -7.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 93.68% | 28.68% | -55.06% | 101.28% | 2.93% |
| Change in Net Operating Assets | -293.39% | -160.48% | 162.86% | -896.98% | -152.63% |
| Cash from Operations | -580.91% | -117.71% | 261.31% | -461.94% | -41.03% |
| Capital Expenditure | -44.68% | -24.88% | 80.66% | -50.93% | -219.13% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -100.00% | 123.53% | -93.41% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 85.64% | 237.03% | -183.12% | 40.79% | 146.63% |
| Cash from Investing | 92.59% | 201.00% | -405.56% | 23.01% | 115.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 85.48% | -345.59% | 0.00% | 77.41% | 33.11% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 75.87% | -4,266.12% | 43.85% | 20.77% | 71.47% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 76.39% | -3,316.51% | 42.33% | 50.52% | 59.17% |
| Foreign Exchange rate Adjustments | -63.64% | 108.21% | -185.35% | 1,844.44% | 86.96% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.72% | 518.81% | 58.21% | -166.46% | 124.38% |